Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?
2012 · British Journal of Cancer · 57 citations
https://doi.org/10.1038/bjc.2012.523
L
Liam Bourke
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
89
Papers
3.1K
Citations
25
h-index
38
i10-index
Liam Bourke is an academic researcher from Mater Misericordiae University Hospital. The author has contributed to research in topics: Cancer survivorship and care & Prostate Cancer Treatment and Research & Prostate Cancer Diagnosis and Treatment. The author has an h-index of 25, co-authored 76 publications.
ORCID: 0000-0001-7107-3926Papers by this author
worksExercise training as a novel primary treatment for localised prostate cancer: a multi-site randomised controlled phase II study
2018 · Scientific Reports · 45 citations
https://doi.org/10.1038/s41598-018-26682-0
Towards implementing exercise into the prostate cancer care pathway: development of a theory and evidence-based intervention to train community-based exercise professionals to support change in patient exercise behaviour (The STAMINA trial)
2021 · BMC Health Services Research · 20 citations
https://doi.org/10.1186/s12913-021-06275-w
A survey to determine usual care after cancer treatment within the United Kingdom national health service
2017 · BMC Cancer · 13 citations
https://doi.org/10.1186/s12885-017-3172-1
Supportive interventions to improve physiological and psychological health outcomes among patients undergoing cystectomy: a systematic review
2018 · BMC Urology · 11 citations
https://doi.org/10.1186/s12894-018-0382-z
Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems
2018 · BMC Cancer · 5 citations
https://doi.org/10.1186/s12885-018-4527-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat